CVS Group plc (LON:CVSG - Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,061.26 ($14.43) and traded as high as GBX 1,276 ($17.35). CVS Group shares last traded at GBX 1,238 ($16.83), with a volume of 88,105 shares trading hands.
CVS Group Price Performance
The company has a 50 day moving average price of GBX 1,254.28 and a 200 day moving average price of GBX 1,068.21. The company has a market capitalization of £880.14 million, a price-to-earnings ratio of 42.51, a PEG ratio of 1.77 and a beta of 1.02. The company has a current ratio of 1.09, a quick ratio of 0.90 and a debt-to-equity ratio of 110.52.
Insider Activity at CVS Group
In other news, insider David Wilton bought 1,000 shares of the stock in a transaction dated Monday, June 2nd. The stock was bought at an average cost of GBX 1,248 ($16.97) per share, with a total value of £12,480 ($16,965.74). Company insiders own 5.83% of the company's stock.
About CVS Group
(
Get Free Report)
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Featured Stories
Before you consider CVS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Group wasn't on the list.
While CVS Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
